AN2 Therapeutics (ANTX) announced a collaboration agreement with GSK (GSK) to develop new therapies for tuberculosis. As part of this effort, the Gates Foundation will provide a third year of funding to support AN2’s work within the collaboration.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ANTX: